Cargando…
COVID-19 Impact on Diabetes Management (iNPHORM, USA)
Autores principales: | Ratzki-Leewing, Alexandria, Harris, Stewart, Black, Jason, Khan, Nadia, Timcevska, Kristina, Ryan, Bridget, Zou, Guangyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596097/ http://dx.doi.org/10.1016/j.jcjd.2021.09.012 |
Ejemplares similares
-
Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US)
por: Black, Jason E., et al.
Publicado: (2023) -
Real‐world risk factors of confirmed or probable COVID‐19 in Americans with diabetes: A prospective, community‐based study (iNPHORM)
por: Ratzki‐Leewing, Alexandria, et al.
Publicado: (2022) -
COVID-19 hinterland: surveilling the self-reported impacts of the pandemic on diabetes management in the USA (cross-sectional results of the iNPHORM study)
por: Ratzki-Leewing, Alexandria A, et al.
Publicado: (2021) -
Predicting Real-world Hypoglycemia Risk in American Adults With Type 1 or 2 Diabetes Mellitus Prescribed Insulin and/or Secretagogues: Protocol for a Prospective, 12-Wave Internet-Based Panel Survey With Email Support (the iNPHORM [Investigating Novel Predictions of Hypoglycemia Occurrence Using Real-world Models] Study)
por: Ratzki-Leewing, Alexandria, et al.
Publicado: (2022) -
Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada
por: Ratzki-Leewing, Alexandria, et al.
Publicado: (2018)